References:

1.             Cristaudo AT, Barat S, Ahmadi N, Morris D. Mutations of the CEACAM5 Gene PELPK Motif in Patients With Appendiceal or Colorectal Adenocarcinoma. In Vivo. 2025;39(1):96-101.

2.             Sarofim M, Wijayawardana R, Ahmadi N, Barat S, Liauw W, Morris DL. Neoadjuvant chemotherapy does not improve survival for patients with high volume colorectal peritoneal metastases undergoing cytoreductive surgery. World J Surg Oncol. 2024;22(1):103.

3.             Morris D, Wijayawardana R, Ahmadi N, Barat S, editors. Difference between Appendiceal and Colon Cancer Management. 14th International Congress of Peritoneal Surface Malignancies; 2024; Lyon, FRANCE. Lyon, FRANCE 2024.

4.             Bhatt A, Villeneuve L, Sardi A, Souadka A, Buseck A, Moran BJ, et al. Correlation of Morphological Appearance of Peritoneal Lesions at Laparotomy and Disease at Pathological Assessment in Patients Undergoing Cytoreductive Surgery for Peritoneal Malignancy: Results of Phase I of the PRECINCT Study in 707 Patients. Ann Surg Oncol. 2024.

5.             Anthony P, Barat S, Ahmadi N, Morris DL. The CEA/PCI ratio is a superior prognosticator than mCOREP for colorectal cancer patients with peritoneal carcinomatosis. Surg Open Sci. 2024;19:28-31.

6.             Torun BC, Glehen O, Kepenekian V, Sardi A, Arjona-Sanchez A, Yonemura Y, et al. Peritoneal metastasis of advanced epithelial ovarian carcinoma treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A retrospective international multicentric data analysis. European Journal of Surgical Oncology. 2023.

7.             Shoma Barat TW, Ruwanthi Wijayawardana, David Morris. Survival outcomes of peritoneal metastases originating from Appendiceal cancers with diaphragmatic involvement after Cytoreduction and HIPEC - abstract. 2023.

8.             Hayler R, Lockhart K, Barat S, Cheng E, Mui J, Shamavonian R, et al. Survival benefits with EPIC in addition to HIPEC for low grade appendiceal neoplasms with pseudomyxoma peritonei: a propensity score matched study. Pleura and Peritoneum. 2023;0(0).

9.             Garrett C, Cristaudo A, Barat S, Morris DL. Increased Incidence of Liver Metastases in Colorectal Versus Appendiceal Adenocarcinoma Peritonectomy Patients Despite Equivocal Survival. Anticancer Res. 2023;43(10):4657-62.

10.          Eshmuminov D, Studer DJ, Lopez Lopez V, Schneider MA, Lerut J, Lo M, et al. Controversy Over Liver Transplantation or Resection for Neuroendocrine Liver Metastasis: Tumor Biology Cuts the Deal. Ann Surg. 2023;277(5):e1063-e71.

11.          Cristaudo AT, Morris DL, Barat S. The 'Starburst' Sign: A Novel Description of PET Images in Carcinoma of Unknown Primary. Anticancer Res. 2023;43(9):4237-9.

12.          Cheng E, Shamavonian R, Mui J, Hayler R, Karpes J, Wijayawardana R, et al. Overall survival and morbidity are not associated with advanced age for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a single centre experience. Pleura Peritoneum. 2023;8(2):83-90.

13.          Cheng E, Shamavonian R, Mui J, Hayler R, Karpes J, Wijayawardana R, et al. Overall survival and morbidity are not associated with advanced age for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a single centre experience. Pleura and Peritoneum. 2023;0(0).

14.          Barat S, Wijayawardana R, Morris D. Outcomes for Colorectal Cancer Cases With Peritoneal Metastases Treated With Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy: A Comparative Analysis of Survival Between Peritoneal Carcinomatosis Scores - PCI in a Single Centre. Anticancer Res. 2023;43(8):3529-38.

15.          Shamavonian R, Cheng E, Karpes JB, Barat S, Ahmadi N, Morris DL. Cytoreductive Surgery and HIPEC for Malignant Peritoneal Mesothelioma: Outcomes and Survival From an Australian Centre. Anticancer Res. 2022;42(6):2939-44.

16.          Roy SP, Al Zhahrani N, Barat S, Morris DL. Case series on high grade appendiceal cancer with peritoneal and liver carcinomatosis undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Int J Surg Case Rep. 2022;94:107027.

17.          MOHAMMAD BREAKEIT DL, ADRIAN CHENG, HYERIM SUH, SHOMA BARAT, AMER MATAR, NAYEF ALZAHRANI, DAVID L. MORRIS. Second-look Surgery for Appendiceal High Grade and Colorectal Cancers Following Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC). in vivo 2022;36:2350 - 6.

18.          Colbourne JRM, Alhayo ST, Nandakumar B, Barat S, Liauw W, Morris DL, et al. Cost-effectiveness of Iterative Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Peritoneal Carcinomatosis. In Vivo. 2022;36(3):1527-33

19.          Shoma Barat NA, Winston Liauw, David Morris. Survival outcomes of Secondary Ovarian Cancer patients with peritoneal metastases with presentation of a high peritoneal carcinomatosis score after Cytoreduction and HIPEC.  Peritoneal Surface Oncology Group International - 2021; Beijing and Online proceedings ; 2021.

20.          Rao A, Mui J, Barat S, Matar AA, Alzahrani N, Morris DL. Peritoneal Spread of Low-grade Appendiceal Tumours - 2 Days of Early Postoperative Intra-peritoneal Chemotherapy Are Enough. Anticancer Res. 2021;41(11):5569-75.

21.          Jasmine Mui AR, Shoma Barat, Vahan Kepenekian, Winston Liauw, Nayef Alzahrani, Prof David Morris. The 5 Year Outcomes of Early Postoperative Intra-Peritoneal Chemotherapy (EPIC) in High-Grade Appendiceal Cancer – Does regimen length and cancer subtype make a difference?  2021; 3(2): 1-7. Surgical Research. 2021;3(2):1 - 7.

22.          Bhatt A, Rousset P, Baratti D, Biacchi D, Benzerdjeb N, I HJTdH, et al. Patterns of peritoneal dissemination and response to systemic chemotherapy in common and rare peritoneal tumours treated by cytoreductive surgery: study protocol of a prospective, multicentre, observational study. BMJ Open. 2021;11(7):e046819.

23.          Bhatt A, Rousset P, Baratti D, Biacchi D, Benzerdjeb N, Hingh Id, et al. Patterns of peritoneal dissemination and response to systemic chemotherapy in common and rare peritoneal tumors treated by cytoreductive surgery: Study protocol of a prospective, multi-center, observational study. medRxiv. 2021.

24.          Alonso A, Barat S, Kennedy H, Potter M, Alzahrani N, Morris D. Risk factors and clinical outcomes in patients undergoing cytoreductive surgery with concomitant ureteric reimplantation. Pleura Peritoneum. 2021;6(4):155-60.